18 January 2021
Two flagship, NIHR-supported studies - REMAP-CAP and RECOVERY - have found no evidence of benefit from convalescent plasma as a treatment for hospitalised patients with COVID-19.
11 January 2021
The number of people seeking help for mental illness or self-harm during April 2020, while the UK was in full lockdown, dropped by more than a third, according to NIHR-funded research.
09 January 2021
Researchers have developed a new risk stratification tool that can accurately predict the likelihood of deterioration in adults hospitalised with COVID-19.
07 January 2021
Patients across the UK who are admitted to intensive care units due to COVID-19 are set to receive a treatment that can reduce the time spent in hospital by up to 10 days, an international study supported by the National Institute for Health Research has found.
30 December 2020
The Medicines & Healthcare Products Regulatory Agency (MHRA) has approved use of the COVID-19 vaccine developed by the University of Oxford and AstraZeneca for people in the UK.
25 December 2020
The world’s first participant in a new antibody treatment study to protect against COVID-19 has been recruited at the University College London Hospitals (UCLH) NHS Foundation Trust.
22 December 2020
Three clinical trial platforms working together to test the effects of full doses of anticoagulants (blood thinners) in COVID-19 patients have paused enrollment for one group of patients.
19 December 2020
The NIHR has published data on participation in COVID-19 urgent public health research by ethnicity - highlighting the importance of people of all ethnicities being represented in studies.
16 December 2020
A UK developed vaccine, pioneered by biotech company Valneva and the only one so far to use an inactive version of the virus, is to be trialled in the UK.
14 December 2020
The NIHR-supported RECOVERY trial has found no clinical benefit from the antibiotic azithromycin for hospitalised patients with severe COVID-19.
11 December 2020
Researchers supported by NIHR have identified potential treatments for Covid-19 after the discovery of five genes associated with the most severe form of the disease.
10 December 2020
The NIHR has funded nine new research projects to help us to better manage current and future waves of the COVID-19 pandemic and investigate its long-term impact on society and the health and care system.
08 December 2020
Data from the NIHR-funded and supported ChAdOx1 nCoV-2019 vaccine, developed by University of Oxford and AstraZeneca, have today become the first Phase 3 trial results of a coronavirus vaccine to be published in peer-review literature
05 December 2020
Over six hundred thousand participants have now taken part in NIHR-supported urgent public health research into Covid-19, in just over eight months.
30 November 2020
The NIHR-supported Novavax Phase 3 COVID-19 vaccine trial has achieved its recruitment target just two months after opening in the UK - with 15,203 volunteers from across the country recruited in record time.
27 November 2020
An online survey by NIHR researchers looking at attitudes to having a future COVID-19 vaccination found that 64% of people would be likely to have a COVID-19 vaccination when one became available.
23 November 2020
The NIHR-funded and supported ChAdOx1 nCoV-2019 vaccine, developed by University of Oxford and AstraZeneca, is effective at preventing COVID-19 and offers a high level of protection, according to international research in more than 24,000 participants.
23 November 2020
A UK study participant is the first in the world to receive a new COVID-19 monoclonal antibody treatment, developed by AstraZeneca.
19 November 2020
Critically ill patients with COVID-19 treated with an arthritis drug that reduces inflammation are more likely to have improved outcomes, an international study supported by NIHR has found.
16 November 2020
From today, 6,000 UK volunteers will be called upon to take part in a phase 3 trial for the COVID-19 vaccine developed by The Janssen Pharmaceutical Companies of Johnson & Johnson.
13 November 2020
Positive results from the early phase trial of a new inhaled antiviral drug have today been published in the Lancet Respiratory Medicine journal. This drug is now moving into a much larger phase 3 trial of patients hospitalised with COVID-19 which is being delivered across England with support from the NIHR.
30 October 2020
Researchers from a leading NIHR-funded and supported study are investigating how to improve the use of antibiotics for patients with COVID-19 at risk of sepsis.
28 October 2020
A new multi-million pound research project will help scientists across the UK to access the data they need to understand the COVID-19 antibody response.
21 October 2020
A model that can calculate a person’s risk of becoming infected and then seriously ill due to COVID-19 has been shown to accurately estimate risk during the first wave of the pandemic in England, in new research funded by the NIHR.
16 October 2020
The NIHR, in partnership with UK Research and Innovation (UKRI), has announced 12 new research projects specifically aimed at tackling the multiple health consequences of the COVID-19 pandemic in low and middle income countries.